Timeline
Avacta settles £3.67m convertible bond payment in cash
AstraZeneca and Ionis ATTR-CM trial fails primary endpoint
OKYO Pharma accelerates urcosimod into Phase 3 after FDA validates trial design
Physiomics wins contracts across two service lines
Coiled Therapeutics advances softgel formulation ahead of dose expansion
Ixico lifts full-year revenue guidance to at least £8m
Health & Bio Today: Frontier IP portfolio company wins EU Parkinson's grant, One Health Group
PureTech spins out Celea Therapeutics with $180m Raise
Health & Bio Today: Genedrive, Physiomics, EMV Capital
Physiomics promotes Head of Biometrics to Chief Operating Officer
EMV Capital portfolio companies Glycotest and ProAxsis raise fresh equity
Health & Bio Today: Oxford BioDynamics appoints new CEO and lands US partnership, Futura Medical, Poolbeg Pharma, Rua Life Sciences
RUA Life Sciences narrows loss and swings to positive EBITDA in first half
Small Caps Today: Oxford BioDynamics appoints new CEO, Kendrick Resources, Cake Box Holdings, Metals One, Gelion . . .
Oxford BioDynamics shows revenue growth, new CEO starts, and lands a new US partnership
Poolbeg Pharma wins South Africa patent for POLB 001 to 2038
Oxford BioDynamics signs contract sales partnership to accelerate US prostate cancer test uptake
Health & Bio Today: Creo Medical lifts FY26 guidance after Q1 beat, Verici Dx, Futura Medical, genedrive, AstraZeneca
Verici Dx posts first full-year Tutivia revenues as test adoption triples
AstraZeneca's Datroway wins EU approval recommendation for first-line triple-negative breast cancer
Genedrive partners Thermo Fisher Scientific to develop high-throughput diagnostic test
Health & Bio Today: Physiomics flags record pipeline after boardroom overhaul, Crism Therapeutics, Panther Securities, Beximco Pharmaceuticals
Crism Therapeutics shares rose after FDA Orphan Drug Designation
BSF Enterprise subsidiary wins four Lions at Cannes 2026 for T-Rex Leather campaign
RTW Bio adds $1.4m to Lycia Therapeutics Series D round targeting food allergy and Graves' disease
Cavendish reiterates 'buy' on HUTCHMED with 436p target after 19% share-price slide
Paraytec agrees heads of terms with US breath-tech firm VosBio to explore lung cancer detection
Agronomics portfolio company Tropic buys banana propagation business Rahan Meristem for $20m
ImmuPharma names Bachem as manufacturing partner for Kapiglucagon drug program
Hutchmed's fanregratinib hits 42.5% response rate in bile duct cancer trial
FDA clears single pivotal trial path for Avacta's AVA6000 in salivary gland cancer
Health & Bio Today: Thalia Therapeutics acquires AML RNA therapy firm in £2.75m-backed deal, Primary Health Properties, Verici Dx, Beximco Pharmaceuticals, Cambridge Cognition
Thalia Therapeutics acquires AML RNA therapy company in deal backed by £2.75m raise
Sareum publishes Phase 1 data on SDC-1801 in peer-reviewed journal
Small Caps Today: Kazera Global seals $10.5m Aftan settlement, Maintel, Proteome Sciences, BATM Advanced Communications, Ondine Biomedical
Avacta starts dosing patients in AVA6103 trial with cash runway extended to early 2027
Solvonis Therapeutics hits key PK milestone for esketamine AUD programme
Proteome Sciences wins chemoproteomics contract ahead of new clinical trial
Genflow Chairman to Join RNA Therapeutics Panel at BIO International Convention
Fusion Antibodies receives Canadian patent allowance for antibody library technology
ValiRx ends University of Dundee drug discovery collaboration after technology fails to meet licensing threshold
Health & Bio Today: Genedrive gains NHS traction in Manchester, Ondine Biomedical, Regional REIT
Syncona life science portfolio rises to £839m as Beacon Therapeutics drives gains
Ondine Biomedical nasal photodisinfection cuts brain surgery infections by 78.5%
Health & Bio Today: Genflow to present gene therapy data in Toronto, Coiled Therapeutics
Coiled Therapeutics adds two oncology specialists to Medical Advisory Board
Genflow to present gene therapy data at Toronto longevity summit
Health & Bio Today: BSF Enterprise, Cizzle Biotechnology, Poolbeg Pharma, Istesso, Inspiration Healthcare
Cizzle Biotechnology Holdings shares skyrocketed after US CLIA approval
More in Healthcare
Genedrive's personalised medicine receives Parliament boost
A government minister named Genedrive's newborn hearing-loss test as a live example of personalised medicine during a House of Commons committee session.